Literature DB >> 18775363

Role of gut hormones in obesity.

Channa N Jayasena1, Steve R Bloom.   

Abstract

A critical role for the gut in energy homeostasis has emerged. Gut hormones not only have a role in digestion but several of them have been found to modulate appetite in animals and humans. Current nonendocrine drugs for obesity are limited by their modest efficacies, and bariatric surgery is confined to use in severe cases. The discovery of important appetite-signaling pathways from the gut to the brain has led to the emergence of several gut hormone-derived drugs that are being investigated for clinical use. This article summarizes the physiology of the major gut hormones implicated in appetite regulation, and reviews clinical evidence that gives us insight into their potential as clinical treatments for obesity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18775363     DOI: 10.1016/j.ecl.2008.07.001

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  12 in total

1.  Effect of Roux-en-Y gastric bypass vs sleeve gastrectomy on glucose and gut hormones: a prospective randomised trial.

Authors:  José Manuel Ramón; Silvia Salvans; Xenia Crous; Sonia Puig; Albert Goday; David Benaiges; Lourdes Trillo; Manuel Pera; Luis Grande
Journal:  J Gastrointest Surg       Date:  2012-03-09       Impact factor: 3.452

2.  Circulating ghrelin and GLP-1 are not affected by habitual diet.

Authors:  Amy C Ellis; Paula Chandler-Laney; Krista Casazza; Laura Lee Goree; Gerald McGwin; Barbara A Gower
Journal:  Regul Pept       Date:  2012-02-28

Review 3.  Physiology of weight loss surgery.

Authors:  Chan W Park; Alfonso Torquati
Journal:  Surg Clin North Am       Date:  2011-12       Impact factor: 2.741

4.  Gastric bypass surgery restores meal stimulation of the anorexigenic gut hormones glucagon-like peptide-1 and peptide YY independently of caloric restriction.

Authors:  Sarah Evans; Zehra Pamuklar; Jonathan Rosko; Patrick Mahaney; Ning Jiang; Chan Park; Alfonso Torquati
Journal:  Surg Endosc       Date:  2011-11-02       Impact factor: 4.584

5.  Pancreatic polypeptide meal response may predict gastric band-induced weight loss.

Authors:  Andrew F R Dixon; Carel W le Roux; Mohammad A Ghatei; Stephen R Bloom; Toni L McGee; John B Dixon
Journal:  Obes Surg       Date:  2011-12       Impact factor: 4.129

Review 6.  Changes in gastrointestinal hormones and leptin after Roux-en-Y gastric bypass procedure: a review.

Authors:  Lauren M Beckman; Tiffany R Beckman; Carrie P Earthman
Journal:  J Am Diet Assoc       Date:  2010-04

7.  Mass spectrometry-based neuropeptidomics of secretory vesicles from human adrenal medullary pheochromocytoma reveals novel peptide products of prohormone processing.

Authors:  Nitin Gupta; Steven J Bark; Weiya D Lu; Laurent Taupenot; Daniel T O'Connor; Pavel Pevzner; Vivian Hook
Journal:  J Proteome Res       Date:  2010-10-01       Impact factor: 4.466

8.  A fine balance: an autoregulatory gene therapy approach to treat obesity and achieve energy homeostasis.

Authors:  S L Samson; M Kohjima; L Chan
Journal:  Gene Ther       Date:  2009-07-23       Impact factor: 5.250

9.  Beyond expectations: the physiological basis of sensory enhancement of satiety.

Authors:  M R Yeomans; R Re; M Wickham; H Lundholm; L Chambers
Journal:  Int J Obes (Lond)       Date:  2016-06-17       Impact factor: 5.095

10.  Changes in gastrointestinal hormones and leptin after Roux-en-Y gastric bypass surgery.

Authors:  Lauren M Beckman; Tiffany R Beckman; Shalamar D Sibley; William Thomas; Sayeed Ikramuddin; Todd A Kellogg; Mohammad A Ghatei; Stephen R Bloom; Carel W le Roux; Carrie P Earthman
Journal:  JPEN J Parenter Enteral Nutr       Date:  2011-03       Impact factor: 4.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.